New shot shows promise for severe Post-Birth depression
NCT ID NCT02614547
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 34 times
Summary
This study tested an experimental drug called SAGE-547 in 21 women with severe postpartum depression. The goal was to see if a single injection could quickly reduce depression symptoms compared to a placebo. The trial was small and early-stage, focusing on safety and how well the drug worked over 60 hours.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE POSTPARTUM DEPRESSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sage Investigational Site
Atlanta, Georgia, 30342, United States
-
Sage Investigational Site
Worcester, Massachusetts, 01655, United States
-
Sage Investigational Site
Chapel Hill, North Carolina, 27514, United States
-
Sage Investigational Site
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.